Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P47989 (
xanthine oxidase
)
8,633
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. Cellulose acetate zymograms of alcohol dehydrogenase (ADH),
aldehyde dehydrogenase
, sorbitol dehydrogenase, aldehyde oxidase, "phenazine" oxidase and
xanthine oxidase
extracted from tissues of inbred mice were examined. 2. ADH isozymes were differentially distributed in mouse tissues: A2--liver, kidney, adrenals and intestine; B2--all tissues examined; C2--stomach, adrenals, epididymis, ovary, uterus, lung. 3. Two NAD+-specific
aldehyde dehydrogenase
isozymes were observed in liver and kidney and differentially distributed in other tissues. Alcohol dehydrogenase, aldehyde oxidase, "phenazine" oxidase and
xanthine oxidase
were also stained when
aldehyde dehydrogenase
was being examined. 4. Two aldehyde oxidase isozymes exhibited highest activities in liver. 5. "Phenazine oxidase" was widely distributed in mouse tissues whereas
xanthine oxidase
exhibited highest activity in intestine and liver extracts. 6. Genetic variants for ADH-C2 established its identity with a second form of sorbitol dehydrogenase observed in stomach and other tissues. The major sorbitol dehydrogenase was found in high activity in liver, kidney, pancreas and male reproductive tissues.
...
PMID:Electrophoretic analyses of alcohol dehydrogenase, aldehyde dehydrogenase, aldehyde oxidase, sorbitol dehydrogenase and xanthine oxidase from mouse tissues. 31 79
A new method for the determination of
xanthine oxidase
activity with xanthine or hypoxanthine is described. The hydrogen peroxide produced by the oxidation of the substrates is reduced by catalase in the presence of high concentrations of ethanol. The acetaldehyde formed is further oxidized by
aldehyde dehydrogenase
NAD or NADP-dependent. The reduction rate of the coenzymes were measured at 334 nm and utilized as indicators for the
xanthine oxidase
. The sensitivity of the method with xanthine as substrate can be doubled by the addition of uricase, which oxidizes uric acid to allantoin.
...
PMID:A new spectrophotometric assay for enzymes of purine metabolism. I. Determination of xanthine oxidase activity. 48 56
A new method for the determination of guanase is described. Xanthine, the product of the guanase reaction, is oxidized by
xanthine oxidase
, forming uric acid and hydrogen peroxide. Hydrogen peroxide is further reduced to water by catalase in the presence of ethanol. The acetaldehyde formed in this reaction step is dehydrogenated NAD or NADP dependent by
aldehyde dehydrogenase
. The NADH or NADPH production is measured and utilized for the calculation of the guanase activity. The sensitivity of the method can be doubled by the addition of uricase, which oxidizes uric acid to permit the formation of another mole of hydrogen peroxide.
...
PMID:A new spectrophotometric assay for enzymes of purine metabolism. II. Determination of guanase activity. 48 57
1. Twenty-six strains of mice were surveyed by starch gel electrophoresis for genetic variation of four liver enzymes;
aldehyde dehydrogenase
, aldehyde oxidase,
xanthine oxidase
and formaldehyde dehydrogenase. 2. A variant of
aldehyde dehydrogenase
was found in strains ICFW, IS/Cam, NZB, NZW, Simpson and Schneider. A variant of aldehyde oxidase was found in CE. A possible variant of
xanthine oxidase
was found in SF/Cam. 3. The gene determining the electrophoretic variant of aldehyde oxidase is either the same as, or very closely linked to, the Aox gene which determines aldehyde oxidase activity.
...
PMID:Genetic variation of some aldehyde-oxidizing enzymes in the mouse. 74 39
Procarbazine, a 1,2-disubstituted hydrazine, is employed therapeutically in the treatment of Hodgkin's disease and a limited number of other neoplasias. The isomeric azoxy metabolites of procarbazine have recently been identified as the precursors of species responsible for both the anti-cancer efficacy and toxic effects mediated by this drug. This study demonstrates that cytosolic enzymes are involved in the metabolism of the azoxy metabolites of procarbazine. Two azoxy procarbazine oxidase activities were resolved by diethylaminoethyl (DEAE)-cellulose chromatography. The activity which did not bind to this column was purified to homogeneity and was identified as a phenobarbital-inducible form of cytosolic
aldehyde dehydrogenase
. This protein fraction was shown to metabolize only the azoxy 2 procarbazine isomer to yield N-isopropy-p-formylbenzamide (ALD) in a reaction which did not require NAD+ as cofactor. The ALD product formed was also a substrate for a subsequent NAD(+)-dependent reduction reaction catalyzed by that purified protein. The azoxy 2 procarbazine isomer and ALD were shown to be potent inhibitors of both the dehydrogenase and esterase activities of
aldehyde dehydrogenase
. The second azoxy procarbazine oxidase activity which was retained by the DEAE-cellulose column co-eluted with
xanthine oxidase
activity. Both the
xanthine dehydrogenase/oxidase
and azoxy procarbazine oxidase activities of this protein fraction were inhibited by allopurinol, a specific inhibitor of xanthine dehydrogenase.
Xanthine dehydrogenase/oxidase
was partially purified by an alternative procedure and was shown to metabolize both the azoxy 2 procarbazine isomer and ALD, ultimately producing N-isopropylterephthalamic acid. The ability of
xanthine oxidase
to metabolize azoxy 2 procarbazine and ALD was confirmed using commercial, purified milk
xanthine oxidase
.
...
PMID:Metabolism of azoxy derivatives of procarbazine by aldehyde dehydrogenase and xanthine oxidase. 168 Jun 57
NAD(P)-linked aldehyde dehydrogenases catalyze the oxidation of a wide variety of aldehydes. Thirteen of these enzymes have been identified in mouse tissues; eleven are found in the liver. Some are substrate-nonspecific; others are relatively substrate-specific. The present investigation sought to determine which of these enzymes are operative in catalyzing the oxidation of retinaldehyde to retinoic acid, a metabolite of vitamin A that promotes the differentiation of epithelial and other cells. Spectrophotometric and HPLC assays were used for this purpose. Enzyme-catalyzed oxidation of retinaldehyde (25 microM) was restricted to the cytosol (105,000 g supernatant fraction) and occurred at a rate of 211 nmol/min/g liver; oxidation of acetaldehyde (4 mM) by this fraction proceeds about ten times faster. At least 90% of this activity was NAD dependent. Of the approximately 10% that was apparently NAD independent, two-thirds was inhibited by 1 mM pyridoxal, a known inhibitor of aldehyde oxidase. Of the six cytosolic aldehyde dehydrogenases, only two, viz. AHD-2 and AHD-7, catalyzed the oxidation of retinaldehyde to retinoic acid. An additional NAD-dependent enzyme, viz.
xanthine oxidase
(dehydrogenase form), also catalyzed the reaction. Catalysis by AHD-2 accounted for more than 90% of the total NAD-dependent activity. Km values were 0.7, 0.6 and 0.9 microM, respectively, for the AHD-2-, AHD-7- and
xanthine oxidase
(dehydrogenase form)-catalyzed reaction. AHD-4, an
aldehyde dehydrogenase
found in the cytosol of mouse stomach epithelium and cornea, did not catalyze the reaction.
...
PMID:Identification of mouse liver aldehyde dehydrogenases that catalyze the oxidation of retinaldehyde to retinoic acid. 188 36
Aldophosphamide, the penultimate cytotoxic metabolite of cyclophosphamide, can be detoxified by an oxidation reaction catalyzed by certain aldehyde dehydrogenases. The selective toxicity of cyclophosphamide is due, at least in part, to a greater expression of the relevant
aldehyde dehydrogenase
activity in normal cells relative to that expressed in certain tumor cells. Not known at the onset of this investigation was which of the several known mouse aldehyde dehydrogenases catalyze this reaction. Twelve enzymes that catalyze the NAD(P)-linked oxidation of aldophosphamide, acetaldehyde, benzaldehyde, and/or octanal were chromatographically resolved from mouse liver. Four of these appear to be novel; four others were determined to be betaine aldehyde dehydrogenase, succinic semialdehyde dehydrogenase, glutamic gamma-semialdehyde dehydrogenase, and
xanthine oxidase
(dehydrogenase). An additional
aldehyde dehydrogenase
, namely AHD-4, was semipurified from stomach. The stomach enzyme and nine of the hepatic enzymes catalyze the oxidation of aldophosphamide. Km values for these reactions range from 16 microM to 2.5 mM. The relevant
aldehyde dehydrogenase
of major importance varies with the tissue. In the liver, the major cytosolic
aldehyde dehydrogenase
, namely AHD-2, accounts for greater than 60% of total hepatic
aldehyde dehydrogenase
-catalyzed aldophosphamide (160 microM) detoxification. Succinic semialdehyde dehydrogenase (AHD-12) and three of the novel hepatic aldehyde dehydrogenases, namely AHD-8, AHD-10, and AHD-13, also contribute significantly to total hepatic
aldehyde dehydrogenase
-catalyzed aldophosphamide detoxification. In the stomach, AHD-4 and AHD-8 account for approximately 86% of total
aldehyde dehydrogenase
-catalyzed aldophosphamide (160 microM) detoxification. AHD-2 was not found in this tissue. Of all the aldehyde dehydrogenases examined, AHD-2 and AHD-8 were estimated to be the most efficient catalysts of aldophosphamide oxidation. Thus, these enzymes would seem most likely to be operative when tumor cells acquire
aldehyde dehydrogenase
-mediated cyclophosphamide resistance.
...
PMID:Identification of the mouse aldehyde dehydrogenases important in aldophosphamide detoxification. 237 64
A method was developed to separate guanase by agarose gel electrophoresis and to detect its activity by staining of the bands with a mixture of the enzymes
xanthine oxidase
, catalase, and
aldehyde dehydrogenase
, the coenzyme NADP+, and a substrate of guanine, ethanol, phenazine methosulfate, nitrotetrazolium blue, and KCN in Tris-(hydroxymethyl)methylamine buffer (pH 8.0). Serum samples showed bands 1 (faster moving) and 2 corresponding to the positions of albumin and alpha 2-globulin, respectively, found by serum protein staining. The same bands were detected with guanase from human liver and kidney, although band 2 from the latter samples was not as distinct as that from the liver samples.
...
PMID:Analysis of guanase by agarose gel electrophoresis and activity staining. 241 96
A single oral administration of ethanol (5 g/kg) to rats induced a marked increase in lipid peroxidation, in the liver and kidney within 9 hr, as assessed by malondialdehyde accumulation. The pretreatment with alcohol dehydrogenase (ADH) inhibitor, 4-methylpyrazole (1 mmol/kg) caused approximately 50% inhibition of the hepatic ADH activity and abolished this ethanol-induced lipid peroxidation. The disulfiram treatment (100 mg/kg) significantly inhibited 63% of the hepatic low Km
aldehyde dehydrogenase
(
ALDH
) but not the high Km
ALDH
. The cyanamide treatment (15 mg/kg) effectively decreased 83% of the low Km and 70% of the high Km
ALDH
in the liver. Although there was more than a 20-fold elevation of acetaldehyde levels by the inhibition of acetaldehyde metabolism with disulfiram or cyanamide, the ethanol-induced lipid peroxidation was significantly suppressed by pretreatment with these drugs. More than 90% inhibition of
xanthine oxidase
and dehydrogenase by the pretreatment with allopurinol (100 mg/kg), with no effect on the hepatic ADH and
ALDH
activities, did not alter the enhancement of lipid peroxidation following ethanol administration. We propose that the metabolism of acetaldehyde (probably via the low Km
ALDH
) and not acetaldehyde itself is responsible for the ethanol-induced lipid peroxidation in vivo and that the contribution of
xanthine oxidase
, as an initiator of lipid peroxidation through acetaldehyde oxidation is minute during acute intoxication.
...
PMID:The metabolism of acetaldehyde and not acetaldehyde itself is responsible for in vivo ethanol-induced lipid peroxidation in rats. 317 76
Isoelectric focusing and electrophoresis were used to identify the various isozymes of alcohol dehydrogenase (ADH),
aldehyde dehydrogenase
(
ALDH
), aldehyde oxidase (AOX), and
xanthine oxidase
(XOX). ADH types I, II, and III were located primarily in the cytosol fraction of liver, but some activity was found also in the small granule fraction. The
ALDH
-I and -IV isozymes were found in the large granule fraction, while
ALDH
-II and -III were present in the cytosol and
ALDH
-V in the small granule fraction. AOX and XOX each appeared as a single cytosolic form with some small granule activity. The tissue distribution of these isozymes is presented and the physiological role of each enzyme is discussed.
...
PMID:Analysis of human alcohol- and aldehyde-metabolizing isozymes by electrophoresis and isoelectric focusing. 389 98
1
2
3
4
Next >>